BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21763261)

  • 1. Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia.
    Chen CC; Pekow J; Llado V; Kanneganti M; Lau CW; Mizoguchi A; Mino-Kenudson M; Bissonnette M; Mizoguchi E
    Am J Pathol; 2011 Sep; 179(3):1494-503. PubMed ID: 21763261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer.
    Kamba A; Lee IA; Mizoguchi E
    Curr Mol Med; 2013 Aug; 13(7):1110-21. PubMed ID: 23170831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
    Kawada M; Seno H; Kanda K; Nakanishi Y; Akitake R; Komekado H; Kawada K; Sakai Y; Mizoguchi E; Chiba T
    Oncogene; 2012 Jun; 31(26):3111-23. PubMed ID: 22056877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells.
    Chen CC; Llado V; Eurich K; Tran HT; Mizoguchi E
    Clin Immunol; 2011 Sep; 140(3):268-75. PubMed ID: 21546314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitinase-3-like protein 1 protects skeletal muscle from TNFα-induced inflammation and insulin resistance.
    Görgens SW; Eckardt K; Elsen M; Tennagels N; Eckel J
    Biochem J; 2014 May; 459(3):479-88. PubMed ID: 24512683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells.
    Mizoguchi E
    Gastroenterology; 2006 Feb; 130(2):398-411. PubMed ID: 16472595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein.
    Kawada M; Chen CC; Arihiro A; Nagatani K; Watanabe T; Mizoguchi E
    Lab Invest; 2008 Aug; 88(8):883-95. PubMed ID: 18490894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression and possible role of chitinase 3-like-1 in a colitis-associated carcinoma model.
    Ma JY; Li RH; Huang K; Tan G; Li C; Zhi FC
    World J Gastroenterol; 2014 Nov; 20(42):15736-44. PubMed ID: 25400457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis.
    Tran HT; Lee IA; Low D; Kamba A; Mizoguchi A; Shi HN; Lee CG; Elias JA; Mizoguchi E
    Inflamm Bowel Dis; 2014 May; 20(5):835-46. PubMed ID: 24694795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
    Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
    Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes.
    Recklies AD; Ling H; White C; Bernier SM
    J Biol Chem; 2005 Dec; 280(50):41213-21. PubMed ID: 16234240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral caffeine administration ameliorates acute colitis by suppressing chitinase 3-like 1 expression in intestinal epithelial cells.
    Lee IA; Low D; Kamba A; Llado V; Mizoguchi E
    J Gastroenterol; 2014 Aug; 49(8):1206-16. PubMed ID: 23925589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats.
    Lv Y; Yang X; Huo Y; Tian H; Li S; Yin Y; Hao Z
    Inflamm Bowel Dis; 2012 Oct; 18(10):1950-60. PubMed ID: 22419609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress.
    Park JA; Drazen JM; Tschumperlin DJ
    J Biol Chem; 2010 Sep; 285(39):29817-25. PubMed ID: 20650887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9.
    Low D; Subramaniam R; Lin L; Aomatsu T; Mizoguchi A; Ng A; DeGruttola AK; Lee CG; Elias JA; Andoh A; Mino-Kenudson M; Mizoguchi E
    Oncotarget; 2015 Nov; 6(34):36535-50. PubMed ID: 26431492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.